Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Immunologic Research
Published in: Immunologic Research 1-2/2015

01-02-2015 | DIAGNOSTICS AND ENVIRONMENTAL FACTORS

A fully automated IIF system for the detection of antinuclear antibodies and antineutrophil cytoplasmic antibodies

Authors: O. Shovman, N. Agmon-Levin, B. Gilburd, T. Martins, A. Petzold, T. Matthias, Y. Shoenfeld

Published in: Immunologic Research | Issue 1-2/2015

Login to get access

Abstract

Indirect immunofluorescence (IIF) is the main technique for the detection of antinuclear antibodies (ANA) and antineutrophil cytoplasmic antibodies (ANCA). The fully automated IIF processor HELIOS® is the first IIF processor that is able to automatically prepare slides and perform automatic reading. The objective of the present study was to determine the diagnostic performance of this system for ANA and ANCA IIF interpretation, in comparison with visual IIF. ANA detection by visual IIF or HELIOS® was performed on 425 sera samples including: 218 consecutive samples submitted to a reference laboratory for routine ANA testing, 137 samples from healthy subjects and 70 ANA/ENA positive samples. For ANCA determination, 170 sera samples were collected: 40 samples for routine testing, 90 samples from healthy blood donors and 40 anti-PR3/anti-MPO positive subjects. Good correlation was found for the visual and automated ANA IIF approach regarding positive/negative discrimination of these samples (kappa = 0.633 for ANA positive samples and kappa = 0.657 for ANA negative samples, respectively). Positive/negative IIF ANCA discrimination by HELIOS® and visual IIF revealed a complete agreement of 100 % in sera from healthy patients and PR3/MPO positive samples (kappa = 1.00). There was 95 % agreement between the ANCA IIF performed by automated and visual IIF on the investigation of routine samples. Based on these results, HELIOS® demonstrated a high diagnostic performance for the automated ANA and ANCA IIF interpretation that was similar to a visual reading in all groups of samples.
Literature
1.
Agmon-Levin N, Damoiseaux J, Shoenfeld Y. Response to: ‘detection of antinuclear antibodies—added-value of solid phase assay?’ by Bossuyt and Fieuws. Ann Rheum Dis. 2014;73:e11.PubMedCrossRef
2.
Fritzler MJ. Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun Rev. 2008;7:616–20.PubMedCrossRef
3.
Tozzoli R, Bizzaro N, Tonutti E, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol. 2002;117:316–24.PubMedCrossRef
4.
Meroni PL, Schur PH. ANA screening: an old test with new recommendations”. Ann Rheum Dis. 2010;69:1420–2.PubMedCrossRef
5.
Nifli AP, Notas G, Mamoulaki M, et al. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum. J Immunol Methods. 2006;311:189–97.PubMedCrossRef
6.
Smith J, Onley D, Garey C, et al. Determination of ANA specificity using the UltraPlex platform. Ann NY Acad Sci. 2005;1050:286–94.PubMedCrossRef
7.
Invernizzi P. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun. 2010;35:436–42.PubMedCrossRef
8.
American College of Rheumatology, “American College of Rheumatology position statement: methodology of testing for antinuclear antibodies.” 2009. pp. 1–3.
9.
Bosch X, Font J, Mirapeix E, et al. Anti-neutrophil cytoplasmic autoantibodies (ANCA): antigenic specificities and clinical associations. Adv Exp Med Biol. 1993;14:281–6.CrossRef
10.
Savige JF, Gillis DF, Benson E, et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol. 1999;14:507–13.
11.
Craig WY, Ledue TB, Collins MF, et al. Serologic associations of anti-cytoplasmic antibodies identified during anti-nuclear antibody testing. Clin Chem Lab Med. 2006;14:1283–6.
12.
Csernok E, Ahlquist D, Ullrich S, et al. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener’s granulomatosis and microscopic polyangiitis. Rheumatology (Oxford). 2002;14:1313–7.CrossRef
13.
Egerer K, Roggenbuck D, Hiemann R et al. Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests. Arthritis Res Ther. 2010;12:R40.
14.
Hiemann R, Hilger N, Michel J, et al. Automatic analysis of immunofluorescencepatterns of HEp-2 cells. Ann NY Acad Sci. 2007;1109:358–71.PubMedCrossRef
15.
Bonroy C, Verfaillie C, Smith V, et al. Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation. Clin Chem Lab Med. 2013;51(9):1771–9.PubMedCrossRef
16.
Voigt J, Krause C, Rohwäder E, et al. Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells. Clin Dev Immunol. 2012;2012:651058.PubMedCentralPubMedCrossRef
17.
Knütter I, Hiemann R, Brumma T, et al. Automated interpretation of ANCA patterns: a new approach in the serology of ANCA-associated vasculitis. Arthritis Res Ther. 2012;14(14):R271.PubMedCentralPubMedCrossRef
18.
Kivity S, Gilburd B, Agmon-Levin N, et al. A novel automated indirect immunofluorescence autoantibody evaluation. Clin Rheumatol. 2011;14:503–9.
19.
Willitzki A, Hiemann R, Peters V, et al. New platform technology for comprehensive serological diagnostics of autoimmune diseases. Clin Dev Immunol. 2012;2012:284740.PubMedCentralPubMedCrossRef
20.
Melegari A, Bonaguri C, Russo A, et al. A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence. Autoimmun Rev. 2012;11:713–6.PubMedCrossRef
21.
Tozzoli R, Bonaguri C, Melegari A, et al. Current state of diagnostic technologies in the autoimmunology laboratory. Clin Chem Lab Med. 2013;51:129–38.PubMedCrossRef
22.
Tozzoli R, Antico A, Porcelli B, et al. Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory. Autoimmun Highlight. 2012;2012(3):59–65.CrossRef
23.
Bizzaro N, Antico A, Platzgummer S, et al. Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems. Autoimmun Rev. 2014;13(3):292–8.PubMedCrossRef
24.
Damoiseaux J, Mallet K, Vaessen M, et al. Automatic reading of ANCA-slides: evaluation of the AKLIDES system. In: Conrad K, Chan EKL, Fritzler MJ, Humbel RL, Meroni PL, Shoenfeld Y, editors. From prediction to prevention of autoimmune disease. Lengerich, Germany: Pabst Science Publishers; 2011. p. 683–4.
25.
26.
Altman D. Practical statistics for medical research. London, UK: Chapman & Hall; 1991.
Metadata
Title
A fully automated IIF system for the detection of antinuclear antibodies and antineutrophil cytoplasmic antibodies
Authors
O. Shovman
N. Agmon-Levin
B. Gilburd
T. Martins
A. Petzold
T. Matthias
Y. Shoenfeld
Publication date
01-02-2015
Publisher
Springer US
Published in
Immunologic Research / Issue 1-2/2015
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-014-8588-y

Other articles of this Issue 1-2/2015

Immunologic Research 1-2/2015 Go to the issue

CUTTING EDGE IN AUTOIMMUNITY

Interleukin-22: Biomarker of maternal and fetal inflammation?

DIAGNOSTICS AND ENVIRONMENTAL FACTORS

Autoimmune diagnostics: the technology, the strategy and the clinical governance

DIAGNOSTICS AND ENVIRONMENTAL FACTORS

Hepatopulmonary syndrome associated with visceral leishmaniasis

Erratum

Erratum to: Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I

DIAGNOSTICS AND ENVIRONMENTAL FACTORS

Vitamin D in primary biliary cirrhosis, a plausible marker of advanced disease

CUTTING EDGE IN AUTOIMMUNITY

The novel panel assay to define tumor-associated antigen-binding antibodies in patients with metastatic melanomas may have diagnostic value